Home Articles List Article Information
Journal of Applied Biotechnology Reports
Journal Archive
Volume Volume 5 (2018)
Volume Volume 4 (2017)
Volume Volume 3 (2016)
Volume Volume 2 (2015)
Volume Volume 1 (2014)
Abdollah, Z., Khodi, S., Gheybi, E., Amani, J., Karami, A. (2018). Recombinant Expression and Purification of Human Cystatin C Biomarker in Escherichia coli for Prediagnostic Renal Disorders. Journal of Applied Biotechnology Reports, 5(1), 13-18.
Zahra Abdollah; Samaneh Khodi; Elaheh Gheybi; Jafar Amani; Ali Karami. "Recombinant Expression and Purification of Human Cystatin C Biomarker in Escherichia coli for Prediagnostic Renal Disorders". Journal of Applied Biotechnology Reports, 5, 1, 2018, 13-18.
Abdollah, Z., Khodi, S., Gheybi, E., Amani, J., Karami, A. (2018). 'Recombinant Expression and Purification of Human Cystatin C Biomarker in Escherichia coli for Prediagnostic Renal Disorders', Journal of Applied Biotechnology Reports, 5(1), pp. 13-18.
Abdollah, Z., Khodi, S., Gheybi, E., Amani, J., Karami, A. Recombinant Expression and Purification of Human Cystatin C Biomarker in Escherichia coli for Prediagnostic Renal Disorders. Journal of Applied Biotechnology Reports, 2018; 5(1): 13-18.

Recombinant Expression and Purification of Human Cystatin C Biomarker in Escherichia coli for Prediagnostic Renal Disorders

Article 3, Volume 5, Issue 1, Winter 2018, Page 13-18  XML PDF (373.07 K)
Document Type: Original Article
Authors
Zahra Abdollah1; Samaneh Khodi1; Elaheh Gheybi2; Jafar Amani email 3; Ali Karami email 4
1Applied Biotechnology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
2Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran
3Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
4Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Receive Date: 11 November 2017,  Revise Date: 03 February 2018,  Accept Date: 15 February 2018 
Abstract
Introduction: Chronic kidney disease is a worldwide health problem and Glomerular filtration rate (GFR) is the most frequently used criteria in the assessment of rental function. Cystatin C as a member of type 2 cystatin superfamily and cysteine-protease inhibitor is found in high concentrations in all biological fluids. This study is aimed to study cystatin C as a potent biomarker for clinical measurement of renal disorders and other diseases.
Materials and Methods: In this study, the human cystatin C construct was analyzed by bioinformatics software. It was cloned and expressed to produce an appropriate antigen for anti-cystatin C (anti-Cys C) obtained from mice Balb/C as a crucial point in the improvement of an enzyme-linked immunosorbent assay (ELISA) method. Serum samples were given from 32 hospitalized patients with renal failure and cardiovascular disease and non-hospitalized patients were tested by ELISA method using anti-Cys C obtained from mice Balb/C.
Results: Our findings indicated 0.36-2.4 mg/L as the best conclusion for antigen cystatin C in patients’ sera and 1/50 dilution for anti-Cys C obtained from mice Balb/C and showed a relationship between patients with high creatinine and high concentration of cystatin C. In case of five cardiovascular disease patients with normal upper limit of Creatinine we obtained cystatin C lower than kidney failure and raising of cystatin C in 6 patients with increased TSH were seen.
Conclusions: Polyclonal anti-Cys C antibodies were obtained through the immunization of Balb/C mice can be employed as an anti-Cys C in ELISA for diagnosis of some renal dysfunction.
Keywords
Creatinine; Cystatin C; Enzyme-Linked Immunosorbent Assay (ELISA); Glomerular Filtration Rate (GFR)
References
  1. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137- 147.
  2. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006;52(1):5-18. doi:10.1373/ clinchem.2005.0525144
  3. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141(12):929-937.
  4. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29. doi:10.1056/NEJMoa1114248
  5. Jung K, Jung M. Cystatin C: a promising marker of glomerular filtration rate to replace creatinine. Nephron. 1995;70(3):370-371. doi:10.1159/000188621
  6. Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis. 2011;58(3):356-365. doi:10.1053/j.ajkd.2011.02.389
  7. Mousa M, El-Saeid M, Hamdy M. Evaluation of Cystatin C, Fibronectin and Alpha-Feto Protein as Biochemical Markers in Patients with Liver Diseases. J Am Sci. 2012;8(7):770-779.
  8. Bengtsson E, To F, Hakansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25(10):2151- 2156. doi:10.1161/01.ATV.0000179600.34086.7d
  9. Gashenko EA, Lebedeva VA, Brak IV, Tsykalenko EA, Vinokurova GV, Korolenko TA. Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer. Int J Circumpolar Health. 2013;72. doi:10.3402/ijch.v72i0.21215
  10. Wilson ME, Boumaza I, Bowser R. Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects. Fluids Barriers CNS. 2013;10(1):15. doi:10.1186/2045-8118-10-15
  11. Andersen TB, Jodal L, Boegsted M, et al. GFR prediction from cystatin C and creatinine in children: effect of including body cell mass. Am J Kidney Dis. 2012;59(1):50-57. doi:10.1053/j. ajkd.2011.09.013
  12. Brguljan PM, Cimerman N. Human cystatin C. Turk J Biochem. 2007;32(3):95-103.
  13. Turk B, Turk D, Salvesen GS. Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des. 2002;8(18):1623-1637.
  14. Dousdampanis P, Trigka K, Fourtounas C. Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate. Aging Dis. 2012;3(5):360-372.
  15. Hayashi M, Iwamoto S, Sato S, et al. Efficient production of recombinant cystatin C using a peptide-tag, 4AaCter, that facilitates formation of insoluble protein inclusion bodies in Escherichia coli. Protein Expr Purif. 2013;88(2):230-234. doi:10.1016/j. pep.2013.01.011
  16. Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest. 1999;104(9):1191-1197. doi:10.1172/jci7709
  17. Chen ZK, Ge CJ, Hu SJ. [The relationship of cystatin C and cardiovascular diseases]. Sheng Li Ke Xue Jin Zhan. 2003;34(3):269-271.
  18. Piwowar A, Knapik-Kordecka M, Buczynska H, Warwas M. Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy. Arch Immunol Ther Exp (Warsz). 1999;47(5):327-331.
  19. Wang F, Pan W, Wang H, Zhou Y, Wang S, Pan S. The impacts of thyroid function on the diagnostic accuracy of cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study. Crit Care. 2014;18(1):R9. doi:10.1186/cc13186
  20. Chew JS, Saleem M, Florkowski CM, George PM. Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev. 2008;29(2):47-62.
  21. Ristiniemi N. Quantification and Clinical Relevance of Cystatin C. Turku, Finland: Annales Universitatis Turkuensis; 2014.
  22. Abdollah Z, Karami A, Amani J, Khodi S, Gheybi E. In silico study of Cystatin C protein to Develop an ELISA kit using Computational tools and servers. Bull Environ Pharmacol Life Sci. 2015;4(7):87- 94.
  23. Heiat M, Aghamollaei H, Hoseini SM, Abbasi Larki R, Yari K. Optimization of plasmid electrotransformation into Escherichia coli using Taguchi statistical method. Afr J Biotechnol. 2012;11(30):7603-7608. doi:10.5897/ajb11.4078
  24. Amani J, Salmanian AH, Rafati S, Mousavi SL. Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7. Vaccine. 2010;28(42):6923-6929. doi:10.1016/j.vaccine.2010.07.061
  25. Assarehzadegan MA, Sankian M, Jabbari F, Tehrani M, Varasteh A. Expression of the recombinant major allergen of Salsola kali pollen (Sal k 1) and comparison with its low-immunoglobulin E-binding mutant. Allergol Int. 2010;59(2):213-222. doi:10.2332/ allergolint.09-OA-0155
  26. Gheybi E, Amani J, Salmanian AH, Mashayekhi F, Khodi S. Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer. Tumour Biol. 2014;35(11):11489-11497. doi:10.1007/s13277- 014-2483-y
  27. Abrahamson M. Human cysteine proteinase inhibitors. Isolation, physiological importance, inhibitory mechanism, gene structure and relation to hereditary cerebral hemorrhage. Scand J Clin Lab Invest Suppl. 1988;191:21-31.
  28. Saitoh E, Sabatini LM, Eddy RL, et al. The human cystatin C gene (CST3) is a member of the cystatin gene family which is localized on chromosome 20. Biochem Biophys Res Commun. 1989;162(3):1324-1331.
  29. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem. 2005;38(1):1-8. doi:10.1016/j. clinbiochem.2004.09.025
  30. Jiang R, Xu C, Zhou X, Wang T, Yao G. Detection of cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits. J Transl Med. 2014;12:205. doi:10.1186/1479-5876-12-205
  31. Dierkes J, Westphal S, Luley C. Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet. 1999;354(9174):219-220. doi:10.1016/s0140-6736(99)02153-4
  32. Cornwall GA, Hsia N. A new subgroup of the family 2 cystatins. Mol Cell Endocrinol. 2003;200(1-2):1-8. doi:10.1016/S0303- 7207(02)00408-2
Statistics
Article View: 70
PDF Download: 99